These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29991500)

  • 1. RORγt-Expressing Tregs Drive the Growth of Colitis-Associated Colorectal Cancer by Controlling IL6 in Dendritic Cells.
    Rizzo A; Di Giovangiulio M; Stolfi C; Franzè E; Fehling HJ; Carsetti R; Giorda E; Colantoni A; Ortenzi A; Rugge M; Mescoli C; Monteleone G; Fantini MC
    Cancer Immunol Res; 2018 Sep; 6(9):1082-1092. PubMed ID: 29991500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
    Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M
    Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
    Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
    J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment.
    Lu Y; Li Y; Liu Q; Tian N; Du P; Zhu F; Han Y; Liu X; Liu X; Peng X; Wang X; Wu Y; Tong L; Li Y; Zhu Y; Wu L; Zhang P; Xu Y; Chen H; Li B; Tong X
    Gastroenterology; 2021 Aug; 161(2):575-591.e16. PubMed ID: 33901495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RORγt expression in T
    Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
    Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.
    Li ZW; Sun B; Gong T; Guo S; Zhang J; Wang J; Sugawara A; Jiang M; Yan J; Gurary A; Zheng X; Gao B; Xiao SY; Chen W; Ma C; Farrar C; Zhu C; Chan OTM; Xin C; Winnicki A; Winnicki J; Tang M; Park R; Winnicki M; Diener K; Wang Z; Liu Q; Chu CH; Arter ZL; Yue P; Alpert L; Hui GS; Fei P; Turkson J; Yang W; Wu G; Tao A; Ramos JW; Moisyadi S; Holcombe RF; Jia W; Birnbaumer L; Zhou X; Chu WM
    Gastroenterology; 2019 Jun; 156(8):2297-2312. PubMed ID: 30836096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of RORγt
    Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
    Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymus-derived Foxp3
    Yang J; Zou M; Pezoldt J; Zhou X; Huehn J
    J Mol Med (Berl); 2018 Dec; 96(12):1387-1394. PubMed ID: 30357435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
    Punkenburg E; Vogler T; Büttner M; Amann K; Waldner M; Atreya R; Abendroth B; Mudter J; Merkel S; Gallmeier E; Rose-John S; Neurath MF; Hildner K
    Gut; 2016 Jul; 65(7):1139-50. PubMed ID: 25838550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RORγt(+) hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice.
    Martin M; Kesselring RK; Saidou B; Brunner SM; Schiechl G; Mouris VF; Wege AK; Rümmele P; Schlitt HJ; Geissler EK; Fichtner-Feigl S
    Eur J Immunol; 2015 Jun; 45(6):1667-79. PubMed ID: 25820779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow CD11b(+)F4/80(+) dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17.
    Zhang L; Fu J; Sheng K; Li Y; Song S; Li P; Song S; Wang Q; Chen J; Yu J; Wei W
    Int Immunopharmacol; 2015 Mar; 25(1):96-105. PubMed ID: 25619457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells.
    Keerthivasan S; Aghajani K; Dose M; Molinero L; Khan MW; Venkateswaran V; Weber C; Emmanuel AO; Sun T; Bentrem DJ; Mulcahy M; Keshavarzian A; Ramos EM; Blatner N; Khazaie K; Gounari F
    Sci Transl Med; 2014 Feb; 6(225):225ra28. PubMed ID: 24574339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-3 suppresses differentiation of RORγt
    Tang W; Saret S; Tian R; Wang H; Claudio E; Murphy PM; Siebenlist U
    Immunol Cell Biol; 2021 Jul; 99(6):586-595. PubMed ID: 33525048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells-regulated Treg cells suppress colitis-associated colorectal cancer.
    Tang RJ; Shen SN; Zhao XY; Nie YZ; Xu YJ; Ren J; Lv MM; Hou YY; Wang TT
    Stem Cell Res Ther; 2015 Apr; 6(1):71. PubMed ID: 25889203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice.
    He Z; He X; Chen Z; Ke J; He X; Yuan R; Cai Z; Chen X; Wu X; Lan P
    Oncol Rep; 2014 Nov; 32(5):1873-80. PubMed ID: 25174408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis.
    Sheng YH; Davies JM; Wang R; Wong KY; Giri R; Yang Y; Begun J; Florin TH; Hasnain SZ; McGuckin MA
    Cell Mol Gastroenterol Hepatol; 2022; 14(4):789-811. PubMed ID: 35809803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases.
    Biagioli M; Di Giorgio C; Morretta E; Bellini R; Massa C; Urbani G; Bordoni M; Marchianò S; Lachi G; Sepe V; Monti MC; Distrutti E; Zampella A; Fiorucci S
    Pharmacol Res; 2024 Oct; 208():107403. PubMed ID: 39265668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close homolog of L1-deficient ameliorates inflammatory bowel disease by regulating the balance of Th17/Treg.
    Yao J; Gao R; Luo M; Li D; Guo L; Yu Z; Xiong F; Wei C; Wu B; Xu Z; Zhang D; Wang J; Wang L
    Gene; 2020 Oct; 757():144931. PubMed ID: 32640308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neomangiferin modulates the Th17/Treg balance and ameliorates colitis in mice.
    Lim SM; Kang GD; Jeong JJ; Choi HS; Kim DH
    Phytomedicine; 2016 Feb; 23(2):131-40. PubMed ID: 26926174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.